Cycurion is trading 5.94% up now at $3.21 after announcing approximately $800,000 in annual contract engagements on September 3, 2026.

  • Awards include pharmaceutical AI Center of Excellence support, new work with NACCHO, and additional commercial and public-health engagements.
  • The announcement is the first public disclosure of these awards and provides a plausible company-specific catalyst; the release does not explicitly attribute the share-price move to them.